Works by Ji, Linong

Results: 389

ADA/EASD Precision Medicine in Diabetes Initiative: An International Perspective and Future Vision for Precision Medicine in Diabetes.

Published in:

2022

By:

Nolan, John J.;
Kahkoska, Anna R.;
Semnani-Azad, Zhila;
Hivert, Marie-France;
Linong Ji;
Mohan, Viswanathan;
Eckel, Robert H.;
Philipson, Louis H.;
Rich, Stephen S.;
Gruber, Chandra;
Franks, Paul W.;
Ji, Linong

Publication type:

journal article

Characteristics and Ongoing Autoimmunity of Patients With Long-standing Type 1 Diabetes Living in China.

Published in:

2018

By:

Wei Liu;
Xueyao Han;
Yanai Wang;
Siqian Gong;
Yumin Ma;
Simin Zhang;
Xueying Gao;
Linong Ji;
Liu, Wei;
Han, Xueyao;
Wang, Yanai;
Gong, Siqian;
Ma, Yumin;
Zhang, Simin;
Gao, Xueying;
Ji, Linong

Publication type:

Letter

Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Published in:

2016

By:

Rubino, Francesco;
Nathan, David M.;
Eckel, Robert H.;
Schauer, Philip R.;
George Alberti, K. M. M.;
Zimmet, Paul Z.;
Del Prato, Stefano;
Linong Ji;
Sadikot, Shaukat M.;
Herman, William H.;
Amiel, Stephanie A.;
Kaplan, Lee M.;
Taroncher-Oldenburg, Gaspar;
Cummings, David E.;
Alberti, K George M M;
Ji, Linong;
Delegates of the 2nd Diabetes Surgery Summit

Publication type:

journal article

Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta-Analysis.

Published in:

2020

By:

Mengdie Hu;
Xiaoling Cai;
Wenjia Yang;
Simin Zhang;
Lin Nie;
Linong Ji;
Hu, Mengdie;
Cai, Xiaoling;
Yang, Wenjia;
Zhang, Simin;
Nie, Lin;
Ji, Linong

Publication type:

journal article

Comparison of the dietary intakes of individuals with and without type 1 diabetes in China.

Published in:

2015

By:

Jaacks, Lindsay M.;
Shufa Du;
Mendez, Michelle A.;
Crandell, Jamie;
Wei Liu;
Linong Ji;
Rosamond, Wayne;
Popkin, Barry M.;
Mayer-Davis, Elizabeth J.;
Du, Shufa;
Liu, Wei;
Ji, Linong

Publication type:

journal article

Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.

Published in:

2020

By:

Xia Li;
Shuting Yang;
Chuqing Cao;
Xiang Yan;
Lei Zheng;
Lanbo Zheng;
Jiarui Da;
Xiaohan Tang;
Linong Ji;
Xilin Yang;
Zhiguang Zhou;
Li, Xia;
Yang, Shuting;
Cao, Chuqing;
Yan, Xiang;
Zheng, Lei;
Zheng, Lanbo;
Da, Jiarui;
Tang, Xiaohan;
Ji, Linong

Publication type:

journal article

Worse Pancreatic [beta]-cell Function and Better Insulin Sensitivity in Older Chinese Without Diabetes.

Published in:

2014

By:

Xiao, Jianzhong;
Weng, Jianping;
Ji, Linong;
Jia, Weiping;
Lu, Juming;
Shan, Zhongyan;
Liu, Jie;
Tian, Haoming;
Ji, Qiuhe;
Yang, Zhaojun;
Yang, Wenying;
China National Diabetes and Metabolic Disorders Study Group

Publication type:

Journal Article

Worse Pancreatic β-cell Function and Better Insulin Sensitivity in Older Chinese Without Diabetes.

Published in:

Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2014, v. 69, n. 4, p. 463, doi. 10.1093/gerona/glt104

By:

Xiao, Jianzhong;
Weng, Jianping;
Ji, Linong;
Jia, Weiping;
Lu, Juming;
Shan, Zhongyan;
Liu, Jie;
Tian, Haoming;
Ji, Qiuhe;
Yang, Zhaojun;
Yang, Wenying

Publication type:

Article

Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.

Published in:

Journal of Diabetes Research, 2018, p. 1, doi. 10.1155/2018/7842064

By:

Huang, Xiuting;
Gong, Siqian;
Ma, Yumin;
Cai, Xiaoling;
Zhou, Lingli;
Luo, Yingying;
Li, Meng;
Liu, Wei;
Zhang, Simin;
Zhang, Xiuying;
Ren, Qian;
Zhu, Yu;
Zhou, Xianghai;
Zhang, Rui;
Chen, Ling;
Gao, Xueying;
Zhang, Fang;
Wang, Yanai;
Han, Xueyao;
Ji, Linong

Publication type:

Article

Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population.

Published in:

Journal of Diabetes Research, 2017, p. 1, doi. 10.1155/2017/3212814

By:

Cai, Xiaoling;
Han, Xueyao;
Zhou, Xianghai;
Zhou, Lingli;
Zhang, Simin;
Ji, Linong

Publication type:

Article

Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population.

Published in:

Journal of Diabetes Research, 2017, p. 1, doi. 10.1155/2017/3212814

By:

Cai, Xiaoling;
Han, Xueyao;
Zhou, Xianghai;
Zhou, Lingli;
Zhang, Simin;
Ji, Linong

Publication type:

Article

Weight reduction and the risk of gallbladder and biliary disease: A systematic review and meta‐analysis of randomized clinical trials.

Published in:

Obesity Reviews, 2024, v. 25, n. 6, p. 1, doi. 10.1111/obr.13725

By:

Yang, Wenjia;
Wu, Han;
Cai, Xiaoling;
Lin, Chu;
Luo, Yingying;
Hu, Suiyuan;
Li, Zonglin;
Jiao, Ruoyang;
Bai, Shuzhen;
Liu, Geling;
Yang, Xiaolin;
Ji, Linong

Publication type:

Article

Attitudes towards therapeutic options for weight management, including weight loss medications and surgery, among people living with obesity and healthcare professionals in China: A secondary analysis from the ACTION‐China study.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3627, doi. 10.1111/dom.16369

By:

Luo, Yingying;
Mu, Yiming;
Chen, Wei;
Wang, Huali;
Zhao, Di;
Liu, Dongmei;
Zhang, Jichun;
Ji, Linong

Publication type:

Article

One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 806, doi. 10.1111/dom.16078

By:

Zhang, Mengqing;
Lin, Chu;
Cai, Xiaoling;
Jiao, Ruoyang;
Bai, Shuzhen;
Li, Zonglin;
Lv, Fang;
Yang, Wenjia;
Liu, Geling;
Yang, Xiaolin;
Ji, Linong

Publication type:

Article

Development and external validation of an algorithm for self‐identification of risk for microvascular complications in patients with type 1 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 740, doi. 10.1111/dom.16068

By:

Liu, Wei;
Hu, Xiaodan;
Fang, Yayu;
Hong, Shenda;
Zhu, Yu;
Zhang, Mingxia;
Gong, Siqian;
Wang, Xiangqing;
Lin, Chu;
Zhang, Rui;
Yin, Sai;
Li, Juan;
Huo, Yongran;
Cai, Xiaoling;
Ji, Linong

Publication type:

Article

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 1, p. 280, doi. 10.1111/dom.16014

By:

Gao, Leili;
Bian, Fang;
Pan, Tianrong;
Jiang, Hongwei;
Feng, Bo;
Jiang, Chengxia;
Sun, Jia;
Xiao, Jianzhong;
Yan, Pangke;
Ji, Linong

Publication type:

Article

Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis.

Published in:

2025

By:

Jiao, Ruoyang;
Lin, Chu;
Cai, Xiaoling;
Wang, Jingxuan;
Wang, Yuan;
Lv, Fang;
Yang, Wenjia;
Ji, Linong

Publication type:

Literature Review

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5013, doi. 10.1111/dom.15915

By:

Ren, Qian;
Li, Ling;
Su, Xiuhai;
Hu, Xiaolin;
Qin, Guijun;
Han, Jie;
Liu, Yu;
Wang, Junmin;
Ji, Linong

Publication type:

Article

Impact of baseline characteristics on the efficacy of once‐weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5312, doi. 10.1111/dom.15888

By:

Ji, Linong;
Lu, Yibing;
Shen, Zewei;
Hu, Ping;
Liu, Wenyan;
Zhang, Qiu;
Shi, Bimin

Publication type:

Article

The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 5466, doi. 10.1111/dom.15862

By:

Ji, Linong;
Gao, Leili;
Feng, Zhikai;
Chen, Guoliang;
Fu, Jing;
Morgan, Erin;
Bhanot, Sanjay;
Gao, Shan;
Zhang, Hongyan;
Liang, Zicai;
Gan, Li‐Ming

Publication type:

Article

Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION‐China study.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4694, doi. 10.1111/dom.15837

By:

Ji, Linong;
Mu, Yiming;
Chang, Cuiqing;
Wang, Huali;
Zhao, Di;
Liu, Dongmei;
Shen, Zewei;
Chen, Wei

Publication type:

Article

Efficacy and safety of tirzepatide in people with type 2 diabetes by baseline body mass index: An exploratory subgroup analysis of SURPASS‐AP‐Combo.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1454, doi. 10.1111/dom.15446

By:

Ma, Jianhua;
Liu, Ming;
Wang, Rui;
Du, Liying;
Ji, Linong

Publication type:

Article

Proportion of participants with type 2 diabetes achieving a metabolic composite endpoint with once‐weekly semaglutide treatment versus comparators: Post hoc pooled analysis from SUSTAIN 1‐5, 7‐10 and SUSTAIN China.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 233, doi. 10.1111/dom.15309

By:

Ji, Linong;
Ahmann, A. J.;
Ahrén, B.;
Capehorn, M. S.;
Hu, P.;
Lingvay, I.;
Liu, W.;
Rodbard, H. W.;
Shen, Z.;
Sorli, C.

Publication type:

Article

Differential effect of interventions in patients with prediabetes stratified by a machine learning‐based diabetes progression prediction model.

Published in:

Diabetes, Obesity & Metabolism, 2024, v. 26, n. 1, p. 97, doi. 10.1111/dom.15291

By:

Zou, Xiantong;
Luo, Yingying;
Huang, Qi;
Zhu, Zhanxing;
Li, Yufeng;
Zhang, Xiuying;
Zhou, Xianghai;
Ji, Linong

Publication type:

Article

A randomized, double‐blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3788, doi. 10.1111/dom.15274

By:

Ji, Linong;
Lu, Jinmiao;
Gao, Leili;
Yan, Xiaoguang;
Li, Jifang;
Cheng, Zhifeng;
Zhang, Lili;
Tian, Junhang;
Li, Ping;
Bai, Jie;
Xie, Daosheng;
Zhao, Jiahong;
Ding, Juping;
Yu, Qiang;
Wang, Tong

Publication type:

Article

Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3671, doi. 10.1111/dom.15261

By:

Ji, Linong;
Lu, Jinmiao;
Gao, Leili;
Ying, Changjiang;
Sun, Jiao;
Han, Jie;
Zhao, Wenhua;
Gao, Yunming;
Wang, Kun;
Zheng, Xin;
Xie, Daosheng;
Ding, Juping;
Zhao, Jiahong;
Yu, Qiang;
Wang, Tong

Publication type:

Article

Efficacy and safety of once‐weekly efpeglenatide in people with suboptimally controlled type 2 diabetes: The AMPLITUDE‐D, AMPLITUDE‐L and AMPLITUDE‐S randomized controlled trials.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2084, doi. 10.1111/dom.15079

By:

Aroda, Vanita R.;
Frias, Juan Pablo;
Ji, Linong;
Niemoeller, Elisabeth;
Nguyên‐Pascal, My‐Liên;
Denkel, Karl;
Espinasse, Melanie;
Guo, Hailing;
Baek, SeungJae;
Choi, JaeDuk;
Lingvay, Ildiko

Publication type:

Article

New insights into the treatment of obesity.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2058, doi. 10.1111/dom.15077

By:

Blüher, Matthias;
Aras, Mohini;
Aronne, Louis J.;
Batterham, Rachel L.;
Giorgino, Francesco;
Ji, Linong;
Pietiläinen, Kirsi H.;
Schnell, Oliver;
Tonchevska, Elena;
Wilding, John P.H.

Publication type:

Article

HbA1c trajectories over 3 years in people with type 2 diabetes starting second‐line glucose‐lowering therapy: The prospective global DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1890, doi. 10.1111/dom.15050

By:

Bongaerts, Brenda;
Kuss, Oliver;
Bonnet, Fabrice;
Chen, Hungta;
Cooper, Andrew;
Fenici, Peter;
Gomes, Marilia B.;
Hammar, Niklas;
Ji, Linong;
Khunti, Kamlesh;
Medina, Jesús;
Nicolucci, Antonio;
Shestakova, Marina V.;
Watada, Hirotaka;
Rathmann, Wolfgang

Publication type:

Article

Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A phase III, randomized, double‐blind, placebo‐controlled, parallel study.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1839, doi. 10.1111/dom.15041

By:

Ji, Linong;
Lu, Yibin;
Li, Qifu;
Fu, Liujun;
Luo, Yong;
Lei, Tao;
Li, Ling;
Ye, Shandong;
Shi, Bimin;
Li, Xiyan;
Meinicke, Thomas

Publication type:

Article

Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double‐blind, placebo‐controlled, Phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1229, doi. 10.1111/dom.14971

By:

Ji, Linong;
Jiang, Xiaozhen;
Hao, Qingshun;
Cheng, Zhifeng;
Wang, Kun;
Pang, Shuguang;
Liu, Meiying;
Guo, Yushan;
Chen, Xiaowen;
Su, Xiuhai;
Ning, Tao;
Liu, Jie;
Bian, Fang;
Li, Yulan;
Zhang, Zhinong;
Song, Weihong;
Sun, Jingfang

Publication type:

Article

Current challenges of diabetes and metabolic disorders in China.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, p. 3, doi. 10.1111/dom.15048

By:

Ji, Linong

Publication type:

Article

Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross‐sectional data.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, p. 5, doi. 10.1111/dom.15029

By:

Lin, Chu;
Zhu, Xingyun;
Jiao, Ruoyang;
Cai, Xiaoling;
Hu, Suiyuan;
Lv, Fang;
Yang, Wenjia;
Li, Zonglin;
Ji, Linong

Publication type:

Article

Efficacy and safety of janagliflozin as add‐on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 785, doi. 10.1111/dom.14926

By:

Gao, Leili;
Cheng, Zhifeng;
Su, Benli;
Su, Xiuhai;
Song, Weihong;
Guo, Yushan;
Liao, Lin;
Chen, Xiaowen;
Li, Jiarui;
Tan, Xingrong;
Xu, Fangjiang;
Pang, Shuguang;
Wang, Kun;
Ye, Jun;
Wang, Yuan;
Chen, Lili;
Sun, Jingfang;
Ji, Linong

Publication type:

Article

A multicentre, randomized, double‐blind, parallel, active‐ and placebo‐controlled Phase 3 clinical study of the glucokinase activator PB‐201 in treatment‐naive patients with type 2 diabetes mellitus: A study protocol.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 649, doi. 10.1111/dom.14909

By:

Du, Ying;
Gao, Leili;
Xiao, Xinhua;
Hou, Xin;
Ji, Linong

Publication type:

Article

Real‐world usage of sulphonylureas in Asian patients with type 2 diabetes using the Joint Asia Diabetes Evaluation (JADE) register.

Published in:

Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 208, doi. 10.1111/dom.14865

By:

Lim, Lee‐Ling;
Lau, Eric S. H.;
Cheung, Johnny T. K.;
Chan, Siew Pheng;
Ji, Linong;
Lim, Soo;
Sirinvaravong, Sirinart;
Unnikrishnan, A. G.;
Luk, Andrea O. Y.;
Cortese, Viviana;
Durocher, Alexandra;
Chan, Juliana C. N.

Publication type:

Article

Factors associated with weight loss in people with overweight or obesity living with type 2 diabetes mellitus: Insights from the global DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1734, doi. 10.1111/dom.14745

By:

Hejjaji, Vittal;
Gorgojo‐Martinez, Juan J.;
Tang, Fengming;
Garnelo, Julia Blanco;
Cooper, Andrew;
Medina, Jesús;
Mutiozabal, Miren Sequera;
Khunti, Kamlesh;
Nicolucci, Antonio;
Shestakova, Marina V.;
Ji, Linong;
Gomes, Marilia B.;
Watada, Hirotaka;
Vora, Jiten;
Malik, Ali O.;
Kosiborod, Mikhail;
Arnold, Suzanne V.

Publication type:

Article

Cardiovascular benefits beyond urinary glucose excretion: A hypothesis generated from two meta‐analyses.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 550, doi. 10.1111/dom.14596

By:

Lin, Chu;
Cai, Xiaoling;
Ji, Linong

Publication type:

Article

What are the factors associated with long‐term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second‐line therapy? Results from the DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2336, doi. 10.1111/dom.14476

By:

Bonnet, Fabrice;
Chen, Hungta;
Cooper, Andrew;
Gomes, Marίlia B.;
Ji, Linong;
Leigh, Paul;
Ramirez, Larisa;
Shestakova, Marina V.;
Shimomura, Iichiro;
Siddiqui, Afrah;
Tang, Fengming;
Vora, Jiten;
Watada, Hirotaka;
Khunti, Kamlesh

Publication type:

Article

Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA‐REG OUTCOME trial with a focus on Asia.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1886, doi. 10.1111/dom.14415

By:

Ji, Qiuhe;
Ji, Linong;
Mu, Yiming;
Zhao, Jiajun;
Zinman, Bernard;
Wanner, Christoph;
George, Jyothis T.;
Zwiener, Isabella;
Ueki, Kohjiro;
Yokote, Koutaro;
Ogawa, Wataru;
Johansen, Odd Erik

Publication type:

Article

Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1956, doi. 10.1111/dom.14401

By:

Khunti, Kamlesh;
Charbonnel, Bernard;
Chen, Hungta;
Cherney, David Z.;
Cooper, Andrew;
Fenici, Peter;
Gomes, Marilia B.;
Hammar, Niklas;
Heerspink, Hiddo J. L.;
Ji, Linong;
Medina, Jesús;
Nicolucci, Antonio;
Ramirez, Larisa;
Rathmann, Wolfgang;
Shestakova, Marina V.;
Shimomura, Iichiro;
Tang, Fengming;
Watada, Hirotaka;
Kosiborod, Mikhail

Publication type:

Article

Associations between second‐line glucose‐lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose‐lowering treatment intensification: The DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1823, doi. 10.1111/dom.14400

By:

Khunti, Kamlesh;
Charbonnel, Bernard;
Cooper, Andrew;
Gomes, Marília B.;
Ji, Linong;
Leigh, Paul;
Nicolucci, Antonio;
Rathmann, Wolfgang;
Shestakova, Marina V.;
Siddiqui, Afrah;
Tang, Fengming;
Watada, Hirotaka;
Chen, Hungta

Publication type:

Article

Flash glucose monitoring data analysed by detrended fluctuation function on beta‐cell function and diabetes classification.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 3, p. 774, doi. 10.1111/dom.14282

By:

Liu, Wei;
Chen, Jing;
He, Luxi;
Cai, Xiaoling;
Zhang, Rui;
Gong, Siqian;
Yang, Xiao;
Wang, Junzheng;
Han, Xueyao;
Shi, Dawei;
Ji, Linong

Publication type:

Article

Use of sodium‐glucose co‐transporter‐2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 299, doi. 10.1111/dom.14251

By:

Khoo, Chin Meng;
Deerochanawong, Chaicharn;
Chan, Siew Pheng;
Matawaran, Bien;
Sheu, Wayne Huey‐Herng;
Chan, Juliana;
Mithal, Ambrish;
Luk, Andrea;
Suastika, Ketut;
Yoon, Kun‐Ho;
Ji, Linong;
Man, Nguyen Huu;
Pollock, Carol

Publication type:

Article

Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 404, doi. 10.1111/dom.14232

By:

Ji, Linong;
Dong, Xiaolin;
Li, Yiming;
Li, Yufeng;
Lim, Soo;
Liu, Ming;
Ning, Zu;
Rasmussen, Søren;
Skjøth, Trine Vang;
Yuan, Guoyue;
Eliaschewitz, Freddy G.

Publication type:

Article

Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspective.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 3, doi. 10.1111/dom.14205

By:

Ji, Linong;
Chan, Juliana C. N.;
Yu, Miao;
Yoon, Kun Ho;
Kim, Sin Gon;
Choi, Sung Hee;
Huang, Chien‐Ning;
Te Tu, Shih;
Wang, Chih‐Yuan;
Paldánius, Päivi Maria;
Sheu, Wayne H. H.

Publication type:

Article

Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.

Published in:

Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 39, doi. 10.1111/dom.14180

By:

Patel, Krishna K.;
Gomes, Marilia B.;
Charbonnel, Bernard;
Chen, Hungta;
Cid‐Ruzafa, Javier;
Fenici, Peter;
Hammar, Niklas;
Ji, Linong;
Kennedy, Kevin F.;
Khunti, Kamlesh;
Kosiborod, Mikhail;
Pocock, Stuart;
Shestakova, Marina V.;
Shimomura, Iichiro;
Surmont, Filip;
Watada, Hirotaka;
Arnold, Suzanne V.

Publication type:

Article

Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2179, doi. 10.1111/dom.14148

By:

Home, Philip;
Blonde, Lawrence;
Kalra, Sanjay;
Linong Ji;
Guyot, Patricia;
Brulle-Wohlhueter, Claire;
Murray, Erin;
Shah, Roshan;
Sayre, Toby;
Shaunik, Alka

Publication type:

Article

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience.

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1436, doi. 10.1111/dom.14052

By:

Zhang, Xiaomei;
Ma, Yujin;
Chen, Hong;
Lou, Ying;
Ji, Linong;
Chen, Lulu

Publication type:

Article

Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII).

Published in:

Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 838, doi. 10.1111/dom.13967

By:

Ji, Linong;
Wan, Hailong;
Wen, Binhong;
Wang, Xueying;
Wang, Junfen;
Bian, Rongwen;
Pang, Wuyan;
Tian, Jian;
Wang, Yan;
Bian, Fang;
Gao, Zhengnan;
Condoleon, Alex;
Feng, Wei;
Zhang, Xia;
Cui, Nan

Publication type:

Article